Zenith Healthcare Limited (BOM:530665)
India
· Delayed Price · Currency is INR 2.960
-0.090 (-2.95%)
At close: Mar 9, 2026
Zenith Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 113.26 | 113.3 | 144.72 | 131.29 | 223.62 | 137.4 | Upgrade
|
| Other Revenue | 0.6 | 0.6 | 0.88 | 0.95 | 1.96 | 1.18 | Upgrade
|
| Revenue | 113.86 | 113.89 | 145.61 | 132.25 | 225.58 | 138.58 | Upgrade
|
| Revenue Growth (YoY) | 2.26% | -21.78% | 10.10% | -41.38% | 62.78% | 14.84% | Upgrade
|
| Cost of Revenue | 47.67 | 55.66 | 85.01 | 81.85 | 127.09 | 82.63 | Upgrade
|
| Gross Profit | 66.19 | 58.23 | 60.59 | 50.4 | 98.49 | 55.95 | Upgrade
|
| Selling, General & Admin | 17.29 | 17.88 | 18.68 | 16.97 | 17.7 | 15.43 | Upgrade
|
| Other Operating Expenses | 44.97 | 39 | 38.65 | 32.05 | 73.93 | 35.75 | Upgrade
|
| Operating Expenses | 65.03 | 59.2 | 59.42 | 51.82 | 95.21 | 53.68 | Upgrade
|
| Operating Income | 1.16 | -0.97 | 1.17 | -1.43 | 3.28 | 2.26 | Upgrade
|
| Interest Expense | - | - | - | -0 | - | -0 | Upgrade
|
| Interest & Investment Income | 2.12 | 2.08 | 0.74 | 0.51 | 0.45 | 0.66 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.18 | 0.18 | 0.18 | 1.98 | 1.59 | 0.98 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.85 | 0.89 | 0.67 | 0.12 | 0.78 | 1.69 | Upgrade
|
| EBT Excluding Unusual Items | 4.3 | 2.18 | 2.76 | 1.18 | 6.1 | 5.58 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.61 | 0.61 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -0.04 | - | Upgrade
|
| Pretax Income | 4.92 | 2.79 | 2.76 | 1.18 | 6.06 | 5.58 | Upgrade
|
| Income Tax Expense | 0.35 | 2.12 | 0.72 | 0.4 | 2.95 | 1.18 | Upgrade
|
| Net Income | 4.57 | 0.67 | 2.04 | 0.78 | 3.11 | 4.4 | Upgrade
|
| Net Income to Common | 4.57 | 0.67 | 2.04 | 0.78 | 3.11 | 4.4 | Upgrade
|
| Net Income Growth | - | -67.08% | 161.57% | -74.95% | -29.40% | -22.23% | Upgrade
|
| Shares Outstanding (Basic) | 53 | 54 | 54 | 54 | 54 | 54 | Upgrade
|
| Shares Outstanding (Diluted) | 53 | 54 | 54 | 54 | 54 | 54 | Upgrade
|
| EPS (Basic) | 0.09 | 0.01 | 0.04 | 0.01 | 0.06 | 0.08 | Upgrade
|
| EPS (Diluted) | 0.09 | 0.01 | 0.04 | 0.01 | 0.06 | 0.08 | Upgrade
|
| EPS Growth | - | -67.08% | 170.49% | -75.78% | -29.40% | -22.03% | Upgrade
|
| Free Cash Flow | - | 2.89 | 16.3 | -9.55 | 10.79 | -16.51 | Upgrade
|
| Free Cash Flow Per Share | - | 0.05 | 0.30 | -0.18 | 0.20 | -0.31 | Upgrade
|
| Gross Margin | 58.13% | 51.13% | 41.61% | 38.11% | 43.66% | 40.37% | Upgrade
|
| Operating Margin | 1.02% | -0.85% | 0.80% | -1.08% | 1.45% | 1.63% | Upgrade
|
| Profit Margin | 4.01% | 0.59% | 1.40% | 0.59% | 1.38% | 3.17% | Upgrade
|
| Free Cash Flow Margin | - | 2.53% | 11.20% | -7.22% | 4.78% | -11.92% | Upgrade
|
| EBITDA | 3.66 | 1.36 | 3.26 | 1.38 | 6.86 | 4.76 | Upgrade
|
| EBITDA Margin | 3.21% | 1.19% | 2.24% | 1.04% | 3.04% | 3.44% | Upgrade
|
| D&A For EBITDA | 2.49 | 2.32 | 2.09 | 2.8 | 3.58 | 2.5 | Upgrade
|
| EBIT | 1.16 | -0.97 | 1.17 | -1.43 | 3.28 | 2.26 | Upgrade
|
| EBIT Margin | 1.02% | -0.85% | 0.80% | -1.08% | 1.45% | 1.63% | Upgrade
|
| Effective Tax Rate | 7.10% | 76.00% | 26.21% | 34.12% | 48.75% | 21.18% | Upgrade
|
| Revenue as Reported | 117.53 | 117.61 | 147.35 | 135.05 | 228.84 | 142 | Upgrade
|
| Advertising Expenses | - | 0.37 | 3.54 | 0.31 | 0.15 | 1.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.